Medicine Iontophoresis Market Drivers
Increasing awareness for treatment of hyperhidrosis is expected to drive growth of the medicine iontophoresis market. For instance, in the U.S., the International Hyperhidrosis Society (IHhS) IHhS celebrates the month of November as Hyperhidrosis Awareness Month by making documentaries, conducting interviews of patients, and organizing various events to raise awareness of hyperhidrosis among the populace.
Moreover, increasing research on iontophoresis in treating various diseases and symptoms is expected to boost growth of the medicine iontophoresis market. For instance, in April 2018, EyeGate Pharma Company developed a novel ocular drug delivery system called EyeGate II iontophoresis, where an electric current generated in the device delivers ionized drug into the eye and further gets absorbed into the eye by the electric current.
Furthermore, approval for new products for medicine iontophoresis therapy is expected to propel the medicine iontophoresis market growth. For instance, in May 2017, Soterix Medical Inc., the U.S.-based firm, received a 510(k) clearance from the U.S. Food and Drug Administration (U.S FDA), for its IontoDC device intended to use direct current to introduce ions of soluble salts or other drugs in the body.
Medicine Iontophoresis Market Restraints
Side effects and the limitations associated with medicine iontophoresis therapy are expected to restrain medicine iontophoresis market growth. For instance, according to British Association of Dermatologists 2016 report, people often complain symptoms of bruising or blisters incase the intensity of current is too high for iontophoresis, a sensation of mild burning in case the electrode is touched, and itchiness in the treated area after treatment. Moreover, patients with cardiac pacemakers or with metal implants are not suitable for iontophoresis treatment.
Furthermore, product recalls due to failure in meeting regulatory standards is expected to restrain growth of the medicine iontophoresis market. For instance, in August 2016, Health Canada recalled IONTODERMA ID-1000, a product of IONTODERMA, due to failure to comply medical devices regulations and for selling medical devices without proper license.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients